Lupus nephritis (LN) is one of the most common manifestations of systemic lupus
erythematosus (SLE), affecting approximately 40% of patients with lupus. It represents a …

Lupus nephritis (LN) is a frequent and severe manifestation of SLE. Along the decades, the
epidemiology of LN and its clinical presentation have been changing. However, even …

Systemic lupus erythematosus (SLE) is a chronic multifactorial autoimmune disease that
affects many organs, including the kidney. Lupus nephritis (LN) is a common manifestation …

Despite the continuing development of immunomodulatory agents and supportive care, the
prognosis associated with lupus nephritis (LN) has not improved substantially in the past …

Over the past year, and for the first time ever, the US Food and Drug Administration
approved 2 drugs specifically for the treatment of lupus nephritis (LN). As the lupus …

Lupus nephritis (LN) is a major cause of morbidity and mortality in patients with systemic
lupus erythematosus. Although the use of aggressive immunosuppression has improved …

Systemic lupus erythematosus is a multisystem autoimmune disease that commonly affects
the kidneys. Lupus nephritis (LN) is the most common cause of kidney injury in systemic …

Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe
organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most …

Lupus nephritis is a common and severe manifestation of systemic lupus erythematosus,
and an important cause of both acute kidney injury and end-stage renal disease. Despite its …

Introduction Lupus nephritis (LN) affects nearly 60% of patients with systemic lupus
erythematosus and up to 30% of them will progress to end-stage renal disease (ESRD) …